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Discussion
AUTHOR
There is a gaping disparity between the way we practise medical 
research and the way we practise medicine; it is a significant void and 
one that shows no signs of shrinking. While the UK and the NHS 
go about treating patients in a deontological fashion, based on the 
principles of an age-old oath of doing no harm, we are utilising cold 
utilitarianism in research on animals.
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The UK general public are animal lovers. Indeed, we were the first 
to introduce animal welfare laws in 1822 (1) and have since led the 
field in the protection of animals used for research and in prevention 
of cruelty to animals through the Animal (Scientific Procedures) 
Act 1986 (2) and the Animal Welfare Act 2006. (3) As is often the 
case, animal welfare laws reflect public opinion and behavior.  It is 
evident from donations to animal welfare charities that we are fond 
of animals; in 2010, the RSPCA and RSPB were the 12th and 15th 
most popular charities in Britain, and the Don-key Sanctuary came 
in five places ahead of Medicines Sans Frontier. (4) On the whole, 
it is fair to say that we shy away from animal cruelty, even towards 
beings not covered by animal welfare laws, such as insects. Cruelty 
to mammals tends to evoke a gut reaction of distaste; testament 
to this is the number of children who become vegetarians after 
learning where burgers come from (though often only until they 
have forgotten their visit to the farm).
Animal research is usually portrayed on a spectrum of vilification. 
That which is done for the de-velopment of cosmetics is widely 
regarded as bad, again reflected in law, this time at a European level, 
with a total ban on all cosmetics or ingredients tested on animals. 
(5) That which is done for non-essential, but beneficial, medical 
treatment is often considered a grey area. And those research studies 
which are credited with directly saving human lives are generally 
perceived to be morally permissible, though for decades the mantra 
of replacing animal research with suitable alternatives wherever 
possible has been preached. (6)
The latter viewpoint is justified on utilitarian grounds; that the 
many will benefit at the expense of the few (or rather, that we 
choose the many to benefit, rather than the few). We permit harm 
to animals based on the assumption that human lives will be saved 
as a result. Early literature that discussed the problems surrounding 
animal testing concentrated on whether or not animals suffer and 
feel pain. It is now generally accepted that they do and science 
muses on the extent to which animals suffer. (7) Furthering our 
understanding of animals is a laudable scientific aim in itself, even 
more so if the knowledge gained is used to justify the replacement 
of animal testing and provide alternatives, thereby reducing animal 
suffering. It is clear that animal testing causes harm to animals but 
that this is done in an attempt to alleviate human suffering. What is 
not clear is the extent to which we should allow this, and where the 
line should be drawn.
Utilitarianism is largely ignored in the day-to-day practice of 
medicine. If you were to patrol the wards looking for organs to 
harvest and old people to kill you would receive a swift notice from 
the GMC and an even swifter visit from the police. As a rule, we 
treat the patient in front of us, ignoring the effects this will have on 
future patients. Doctors do play a pivotal role in deciding where 
the government spends its healthcare budget, but these are specific 
doctors, away from the patients their decisions will impact. With 
the exception of some policies, such as the Cancer Drugs Fund, 
which remain controversial or are even publicly lambasted, we 
allocate resources on a strict rule-utilitarian basis; those services 
that can provide so many Quality Adjusted Life Years, for so much 
funding, are adopted. This enables us to do the most good for the 
most number of people, while never having to deny someone a 
reasonable treatment.
Unlike resource allocation, and like day-to-day practice, research 
does not usually operate on a utilitarian basis; this is solely reserved 
for animal testing. Placebo controlled studies in humans are 
frequently impermissible because they would require one cohort 
to receive suboptimal care. If early results from a study show 
significant detrimental effects, the study is stopped. All research 
proposals must undergo rigorous ethical approval. If you want to 
deceive a study participant, or expose them to potential harm, you 
would need to obtain full and informed consent from volunteers. 
Pharmaceutical research in pregnancy and children is near enough 
impossible to complete because the risk to both mother and child 
is deemed to be too high, no matter how promising the treatment 
or intervention under investigation nor how great the benefit may 
be to others. This, rightly, is not a utilitarian approach. First, do no 
harm.
The problem of inconsistency arises. If exposing human volunteers 
to sub-optimal treatment is unacceptable, why is it acceptable to test 
on animals in order to advance human medical knowledge? To do 
so is not in-keeping with traditional, deontological medical practice 
in the UK. Doctors do not sell their patients down the river because 
there is greater benefit to be found in their sacrifice - this would 
go against the very essence of deontology, which focuses on the 
duty itself: the duty of a doctor to protect each person who comes 
under their care, as an individual and irrespective of the impact 
this may or may not have on others.  The inconsistency is this: we 
request expensive emergency procedures because we worry that it 
could be us or a loved one in that emergency room next, no matter 
how much more efficiently that money could be spent, but we also 
support animal testing because it benefits the human race, despite 
causing direct suffering to animals. It would appear we have a 
double standard. It is a tricky balance and these are tricky questions, 
which is why we do not expect the public to proportion the health 
care budget. We do, however, expect our regulatory, governing, and 
funding bodies to have considered their approach to the situation 
and come at it with some consistency.
It might be argued that ‘first, do no harm’ is applicable to humans 
only, and that, therefore, we are not in breach of our deontological 
principles by causing harm to animals to better treat ourselves. 
However, as a rule this is not how we behave. We have already 
discussed animal protection laws which prevent the total disregard 
of animal welfare, and our tendencies to donate to animal charities. 
All of these things benefit animals, arguably with some detriment 
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to humans and yet we go about them anyway. If this were a 
deontological principle, we would be in direct contradiction to it. 
Likewise, the issue of pragmatism should not feature in this 
discussion; whether test ‘A’ or test ‘B’ is more efficient has no 
bearing on their ethical consistency with test ‘C’. Of course, it 
would be more expensive, time consuming and restrictive to 
medical research if we only tested on humans, but the argument I 
am presenting concerns consistency. You can believe that animal re-
search should continue and still appreciate that we do not conduct 
research in a way that is con-sistent with other ethical principles in 
medicine.
It seems that we are justifying animal testing by applying utilitarian 
principles to our actions, but this is not something we do anywhere 
else in medical treatment or research. Utilitarianism in healthcare 
is not used to support harm-doing and it would be worrying if 
it were. While we understandably want to do good for our own 
species, it is in opposition to our visceral reactions and reflected 
beliefs to harm other species in the process. The tide has already 
turned on cosmetic research; perhaps it is not a case of if, but when, 
we will look back on animal testing in medical research as a breach 
of our moral code. The medical profession may be hesitant to 
accept it, but if we are to maintain consistency in our convictions, 
research must only be conducted on consenting volunteers. 
Permitting harm to one being for the sake of another is the epitaph 
of an uncaring society. 
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